SK Group has partnered with global investment firm Kohlberg Kravis Roberts (KKR) to launch South Korea’s largest renewable ...

A novel nickel-free, low-profile TAVI valve shows promise in treating severe aortic stenosis, according to first-in-human ...

Taysha Gene Therapies (TSHA) remains a Buy on strong TSHA-102 Rett data, FDA-aligned pivotal path, and cash to 2028—read the ...

Without a clear view of where sensitive data lives, who can access it and how it moves, blind spots can quickly turn into ...

Customer success across consumer goods, retail, healthcare and life sciences highlights EPAM's impact in helping enterprises ...

KPMG's 2026 M&A research identified leadership and culture misalignment as dealmakers biggest post-merger challenges. New AI ...

Let's examine a practical readiness framework for operations leaders can use to assess the data infrastructure before ...

Mostly right is the wrong bar,” Pearl CEO Andy Kurtzig says, as research tests top AI models against professional judgment.

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that the UK Medicines & Healthcare products Regulatory Agency ...

Genome editing lets scientists rewrite DNA, the instruction manual inside every living cell, with a precision that was unthinkable a generation ago. Technologies such as CRISPR have made this almost ...

Travis Nixon will now serve as the company's chief data and AI officer while Tom Hutchins will tackle the CTO role.